View Older Stories View More Recent Stories

May 31, 2017 04:30PM Esperion to Present at the Jefferies 2017 Global Healthcare Conference
May 22, 2017 08:09AM Esperion (ESPR) Comments on Report Containing 'Inaccurate Information'
May 22, 2017 08:05AM Esperion Provides Update on Common Stock Trading Activity
May 19, 2017 04:30PM Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference
May 18, 2017 04:30PM Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 12, 2017 04:30PM Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2017 Healthcare Conference
May 4, 2017 04:05PM Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial Results
Mar 28, 2017 04:30PM Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare Conference
Mar 20, 2017 07:31AM Esperion Therapeutics (ESPR) Says FDA Confirms LDL-C Lowering Indication for Bempedoic
Mar 20, 2017 07:30AM Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic Acid
Mar 7, 2017 08:30AM Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of Bempedoic Acid/Ezetimibe/Atorvastatin
Mar 6, 2017 08:34AM Esperion Therapeutics (ESPR) Mendelian Randomization Study Results to Be Presented at ACC
Mar 6, 2017 08:30AM Esperion Announces Oral Presentation on Genetic Validation of ATP Citrate Lyase Inhibition at the American College of Cardiology 66th Annual Scientific Session
Feb 22, 2017 07:30AM Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 15, 2017 04:30PM Esperion to Participate in Fireside Chat at RBC Capital Markets Global Healthcare Conference
Jan 25, 2017 08:08AM Esperion Therapeutics (ESPR) Completes Enrollment of Pivotal Phase 3 Long-Term Safety and Tolerability Study of Bempedoic Acid
Jan 25, 2017 08:05AM Esperion Completes Enrollment of Pivotal Phase 3 Long-Term Safety and Tolerability Study of Bempedoic Acid in Patients with Hypercholesterolemia
Jan 9, 2017 08:08AM Esperion Therapeutics (ESPR) Initiates CVOT Trial for Bempedoic Acid
Jan 9, 2017 08:05AM Esperion Announces Initiation of Global Cardiovascular Outcomes Trial for Bempedoic Acid
Jan 8, 2017 04:00PM Esperion Announces Initiation of Three Pivotal Phase 3 Studies for Bempedoic Acid
Jan 4, 2017 05:00PM Esperion to Present at the 35th Annual J.P. Morgan Healthcare Conference
Nov 28, 2016 04:32PM Esperion Therapeutics (ESPR) Announces Publication of Bempedoic Acid Data in LDL-C
Nov 28, 2016 04:30PM Esperion Therapeutics Announces Publication of Definitive Paper on Bempedoic Acid Mechanism of Action in Nature Communications
Nov 9, 2016 04:30PM Esperion Therapeutics to Present at the Stifel 2016 Healthcare Conference
Nov 3, 2016 04:05PM Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results
Nov 1, 2016 04:30PM Esperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare Conference
Oct 13, 2016 12:05PM Streetinsider.com's Hot Lunchtime Reads 10/13: (TWTR) (ESPR) (SSYS) (APTO)
Oct 13, 2016 07:33AM Esperion Therapeutics (ESPR) Says Pivotal Phase 3 LDL-C to Include Patients on Any Statin, at Any Dose
Oct 13, 2016 07:30AM Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose
Aug 4, 2016 04:05PM Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Second Quarter 2016 Financial Results
Jun 28, 2016 04:10PM Esperion Therapeutics (ESPR) Provides Update on Bempedoic Acid; FDA Says Regulatory Pathway for LDL-C Lowering Indication Not Well Defined
Jun 28, 2016 04:05PM Esperion Therapeutics Provides Clinical Development and Regulatory Update for Bempedoic Acid
May 4, 2016 08:05AM Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2016 Financial Results
Mar 8, 2016 04:30PM Esperion Therapeutics to Present at the Barclays Global Healthcare Conference
Feb 25, 2016 04:05PM Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 16, 2016 04:30PM Esperion Therapeutics to Present at the 2016 RBC Capital Markets Global Healthcare Conference
Jan 20, 2016 04:09PM Stocks Close Down But Not Before Rip Your Face Off Rally in Beaten Down Names
Jan 14, 2016 07:48PM SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Esperion Therapeutics, Inc. and Advises Investors With Losses in Excess of $100,000 to Contact the Firm
Jan 13, 2016 08:50PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Esperion Therapeutics, Inc. and Advises Investors with Losses in Excess of $100,000 to Contact the Firm
Jan 13, 2016 08:31AM Esperion Therapeutics (ESPR) Commences Bempedoic Acid Phase 3 in Certain Hyperlipidemia
Jan 13, 2016 08:30AM Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study
Jan 12, 2016 04:05PM Esperion Therapeutics Announces Initiation of Phase 2 Clinical Study of Bempedoic Acid in Patients Treated With High-Dose Statin Therapy
Jan 6, 2016 04:30PM Esperion Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference
Nov 6, 2015 08:30AM Esperion Therapeutics to Present at November Healthcare Conferences
Nov 5, 2015 04:05PM Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2015 Financial Results
Nov 4, 2015 04:30PM Esperion Therapeutics Announces Two Oral Presentations for ETC-1002 at the American Heart Association Scientific Sessions 2015
Oct 12, 2015 09:31AM Pre-Open Stock Movers 10/12: (ESPR) (OREX) (EMC) Higher; (MHR) (SIEN) (LLY) Lower (more...)
Sep 28, 2015 04:30PM Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes
Aug 17, 2015 04:05PM Esperion Therapeutics Provides Update on the ETC-1002 Development Program Following End-of-Phase 2 Meeting With FDA
Aug 10, 2015 09:33AM Pre-Open Stock Movers 08/10: (AQXP) (VLTC) (INO) (PCP) Higher; (SYN) (JD) (FCX) Lower (more...)
View More Recent Stories View Older Stories